A Multi-Modality Assay Platform for Ultra-High Throughput Screening

Author(s): A. Fowler, I. Davies, C. Norey

Journal Name: Current Pharmaceutical Biotechnology

Volume 1 , Issue 3 , 2000

Become EABM
Become Reviewer


The demand for increased throughput during primary screening using less reagents is changing the way of drug discovery. Searching for hits using high throughput screening in 96-well format plates is being replaced by the use of higher density plates, such as 384 and 1536-well formats. The analysis of radiometric assays by scintillation counters is becoming limiting since only 12 wells can be counted at a time. Charged coupled device (CCD) camera based instruments, that image the whole plate in one exposure, speed up detection and are compatible with any microplate footprint. Researchers are also demanding a choice of detection methods, including fluorescence, luminescence and radioactivity, and require imagers suitable for all applications. LEADseekerä Homogenous Imaging System is a multi-modality platform offering imaging technology and assay toolboxes for radiometric, fluorescent and luminescent based assays. LEADseeker allows the very rapid analysis of high density formats enabling ultra-high thr oughput screening of a range of biological assays. Research areas that can be studied using this system include enzyme assays, receptor binding and molecular interactions.

Keywords: Multi modality assay platform, Ultra high throughput screening, Charged coupled device, Enzyme assay, Receptor binding

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2000
Page: [265 - 281]
Pages: 17
DOI: 10.2174/1389201003378933
Price: $65

Article Metrics

PDF: 2